GEMMA FRISIUS FUND
On July 3, 2002 the Gemma Frisius Fund II was established. Continuing the work of its predecessor Gemma Frisius Fund I, this is a venture capital fund providing seed capital and start-up capital to spin-off companies intending to commercialize knowledge and research developed at K.U.Leuven. Following the success of the first edition of the Fund, the three partners - Fortis Private Equity, KBC Investco and K.U.Leuven Research & Development - unanimously decided to extend this unique form of coope... ration between the academic and financial worlds. The Gemma Frisius Fund I invested in 15 projects, for a total value of 8 million eur. The fund still has 4.4 million eur available for follow-up investment in these projects. The new fund will not invest in companies belonging to the portfolio of the first edition of the fund. The management structure of the Gemma Frisius Fund II will remain the same. The projects are analyzed in an advisory committee and presented for approval to the board of directors. Two directors from each partner are represented on the board.
GEMMA FRISIUS FUND
Status:
Active
Similar Organizations
FIRST
FIRST aims to inspire young people to be science and technology leaders.
Monell Chemical Senses Center
Monell Chemical Senses Center is a non-profit independent scientific institute located at the University City Science Center
University of Vienna
University of Vienna promotes partnerships and collaborations while excelling in science, research, and teaching within a global setting.
Wistar Institute
The Wistar Institute is the nation’s first independent institution devoted to medical research and training.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | AstriVax | Gemma Frisius Fund investment in Seed Round - AstriVax | 30 M EUR |
| 2021-04-14 | Aphea.Bio | Gemma Frisius Fund investment in Series B - Aphea.Bio | 18 M EUR |
| 2021-04-01 | Aphea.Bio | Gemma Frisius Fund investment in Series B - Aphea.Bio | 4 M EUR |
| 2020-11-01 | Runeasi | Gemma Frisius Fund investment in Seed Round - Runeasi | 350 K EUR |
| 2020-05-28 | Virovet | Gemma Frisius Fund investment in Series B - Virovet | 6 M EUR |
| 2019-12-16 | Augustine Therapeutics | Gemma Frisius Fund investment in Seed Round - Augustine Therapeutics | 4.2 M EUR |
| 2019-09-12 | MyCellHub | Gemma Frisius Fund investment in Seed Round - MyCellHub | 1.1 M EUR |
| 2019-07-15 | ArtiQ | Gemma Frisius Fund investment in Seed Round - ArtiQ | 1000 K EUR |
| 2019-05-17 | Elimity | Gemma Frisius Fund investment in Seed Round - Elimity | 800 K EUR |
| 2018-12-18 | reMYND | Gemma Frisius Fund investment in Series B - reMYND | 12 M EUR |
More informations about "Gemma Frisius Fund"
Gemma Frisius Fund — KU Leuven Research & Development
Mar 7, 2022 A partner in spin-off creation. Gemma Frisius Fund (GFF) is a seed capital fund, established in 1997 as a joint venture between KU Leuven, KBC Private Equity and BNP …See details»
Gemma Frisius Fund - Crunchbase Investor Profile
Jun 26, 2013 On July 3, 2002 the Gemma Frisius Fund II was established. Continuing the work of its predecessor Gemma Frisius Fund I, this is a venture capital fund providing seed capital and start-up capital to spin-off companies …See details»
Gemma Frisius Fund: Performance - PitchBook
Feb 8, 2024 Gemma Frisius Fund is an early-stage venture capital fund co-managed by the University of Leuven, KBC Group, and BNP Paribas. The fund is located in Leuven, Belgium. …See details»
Gemma Frisius Fund - Investments, Portfolio & Company Exits
Jun 26, 2024 On July 3, 2002 the Gemma Frisius Fund II was established. Continuing the work of its predecessor Gemma Frisius Fund I, this is a venture. Search Crunchbase. Start Free …See details»
Gemma Frisius Fund (GFF) (KU Leuven + KBC Private Equity + BNP …
Jan 1, 1997 Gemma Frisius Fund (GFF) is a seed capital fund, established in 1997 as a joint venture between KU Leuven, KBC Private Equity and BNP Paribas Fortis Private Equity. It …See details»
Gemma Frisius Fund - VC Firm Profile - Gaebler.com Venture …
Gemma Frisius Fund invests in innovation by backing companies focused on high-impact, technology-driven solutions. Venture Investor Overview. Venture Investor. Gemma Frisius …See details»
Gemma Frisius Fund — 33 Investments, Portfolio, Team members …
Opposing the other organizations, this Gemma Frisius Fund works on 9 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 …See details»
Gemma Frisius Fund - Private Equity List
Gemma Frisius Fund. Investor type. VC. Last fund created. 1425. AUM-Location. Belgium. $1-5 m. Investment Ticket. 3-5 years. Investment Horizon. ... Private Equity Venture Capital Angel …See details»
Obulytix raises € 4 million round in Seed funding - Qbic
Bram Perdu, Investment Manager at the Gemma Frisius Fund concluded: “Our Fund’s aim is to stimulate the creation and growth of spin-off companies from research at KU Leuven. Obulytix …See details»
Gemma Frisius Fund (investor) - Nordic 9
Gemma Frisius Fund (GFF) is a seed capital fund, established in 1997 as a joint venture between KU Leuven, KBC Group and BNP Paribas Group. Average round investment: 14.09M USD …See details»
Gemma Frisius Fund - Contacts, Employees, Board Members
On July 3, 2002 the Gemma Frisius Fund II was established. Continuing the work of its predecessor Gemma Frisius Fund I, this is a ventureSee details»
VersaSense secures funding from Gemma Frisius Fund to expand …
Oct 10, 2018 VersaSense, a privately held Belgian industrial Internet of Things (IoT) company, today announced the completion of a financing round with the Gemma Frisius Fund.Existing …See details»
Gemma Frisius Fund KU Leuven (GFF) - CB Insights
About Gemma Frisius Fund KU Leuven (GFF) Gemma Frisius Fund K.U.Leuven (GFF) is a seed capital fund. It was founded on October 14, 1997 as a joint venture involving the K.U.Leuven …See details»
Centre for Drug Design and Discovery (CD3) raises €70.5 million
Oct 18, 2023 The Centre for Drug Design and Discovery (CD3), a pioneering organization specializing in translating innovative biomedical research into life-saving medicines, today …See details»
REIN4CED completes capital round | Leuven MindGate
Gemma Frisius Fund, the seed capital fund of KU Leuven, supports REIN4CED in research and technology as well as financial and business aspects. Finindus offers extensive expertise in …See details»
Gemma Frisius Fund - Updates, News, Events, Signals & Triggers
On July 3, 2002 the Gemma Frisius Fund II was established. Continuing the work of its predecessor Gemma Frisius Fund I, this is a ventureSee details»
Gemma Frisius Fonds KU Leuven - company portfolio - YouTube
Gemma Frisius Fund KU Leuven has supported the creation and growth of 50 high-tech companies, which all develop innovative technologies with impact on society.See details»
Obulytix is developing a revolutionary solution for antibiotic ...
Dec 5, 2023 About Gemma Frisius Fund. Gemma Frisius Fund (GFF) is a seed capital fund, established in 1997 as a joint venture between KU Leuven, KBC Group and BNP Paribas …See details»
Sustainable protein seed start-up Protealis doubles capital ... - Korys
Feb 9, 2021 Gemma Frisius Fund (GFF) is a seed capital fund, established in 1997 as a joint venture between KU Leuven, KBC Group and BNP Paribas Group. The objective of the fund is …See details»
Managing Director @ Gemma Frisius Fund - Crunchbase
Paul Van Dun serves as Managing Director at Gemma Frisius Fonds N.V. In 1991 Paul Dun joined KPMG, after which he took up a position with Investco/LPM, the private equity and …See details»